Search

Author/Creator Reinhardt, C.

1. 17LBA Results from an open-label, randomized, controlled Phase 3 study investigating IMA901 multipeptide cancer vaccine in patients receiving sunitinib as first-line therapy for advanced/metastatic RCC. (September 2015)

Authors:
Rini, B.; Stenzl, A.; Zdrojowy, R.; Kogan, M.; Shkolnik, M.; Oudard, S.; Weikert, S.; Bracarda, S.; Crabb, S.; Bedke, J.; Ludwig, J.; Maurer, D.; Mendrzyk, R.; Mahr, A.; Fritsche, J.; Weinschenk, T.; Singh, H.; Kirner, A.; Reinhardt, C.; Eisen, T.
Journal:
European journal of cancer
Issue:
Volume 51:(2015)Supplement 3
Page Start:
S718
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

6. P1317: TIME SERIES CLUSTERING OF T CELL SUBSETS DISSECTS HETEROGENEITY IN IMMUNE RECONSTITUTION AND SURVIVAL AMONG RECIPIENTS OF MUD-HCT WITH ATG OR PTCY. (23rd June 2022)

Authors:
Turki, A.; Leserer, S.; Graf, T.; Buttkereit, U.; Arrieta-Bolanos, E.; Leimkühler, N.; Fleischhauer, K.; Beelen, D.; Reinhardt, C.
Journal:
HemaSphere
Issue:
Volume 6(2022)Supplement 3
Page Start:
1202
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗